BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22263591)

  • 1. Pharmacokinetics, tissue distribution, excretion, and metabolism of a new cardioprotective agent 10-O-dimethylaminoethylginkgolide B in rats.
    Wang DL; Peng DY; Liu XD; Zhang X; Chen WD; Liang Y; Wang XT; Xie T; Xie L; Wang GJ
    J Asian Nat Prod Res; 2012; 14(1):27-38. PubMed ID: 22263591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics analysis of XQ-1H and its combination therapy with clopidogrel on cerebral ischemic reperfusion injury in rats.
    Khadankhuu B; Fei Y; Xu D; Li Y; Hou K; Li F; Fang W; Chen X; Li Y
    J Pharm Biomed Anal; 2020 Feb; 179():112975. PubMed ID: 31735472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Metabolism and Disposition of [14C]XQ-1H After Intravenous Administration to Male Rats.
    Qin Y; Chen T; Jin Q; Guo K; Feng H; Heller D; Gu ZM
    Drug Metab Lett; 2017; 10(4):228-239. PubMed ID: 28103788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model.
    Wang S; Ouyang B; Aa J; Geng J; Fei F; Wang P; Wang J; Peng Y; Geng T; Li Y; Huang W; Wang Z; Xiao W; Wang G
    J Pharm Biomed Anal; 2016 Jul; 126():109-16. PubMed ID: 27182682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
    Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
    Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.
    Kumar V; Schuck EL; Pelletier RD; Farah N; Condon KB; Ye M; Rowbottom C; King BM; Zhang ZY; Saxton PL; Wong YN
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):229-37. PubMed ID: 21698359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic time window for treatment of focal cerebral ischemia reperfusion injury with XQ-1h in rats.
    Sun J; Li Y; Fang W; Mao L
    Eur J Pharmacol; 2011 Sep; 666(1-3):105-10. PubMed ID: 21645512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the ginkgo B following intravenous administration of ginkgo B emulsion in rats.
    Chen WD; Liang Y; Xie L; Lu T; Liu XD; Wang GJ
    Biol Pharm Bull; 2007 Jan; 30(1):1-5. PubMed ID: 17202649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agent cis-(-)-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido-[4,3-b]indole dihydrochloride in rats.
    Kállay Z; Bittererová J; Brejcha A; Faberová V; Bezek S; Trnovec T
    Arzneimittelforschung; 1990 Sep; 40(9):974-9. PubMed ID: 2080947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cyclosporine A on the pharmacokinetics of ginkgolide B in rats].
    Wang L; Li N; Han DE; Sun W; Gao ZD; Chen XJ
    Yao Xue Xue Bao; 2009 Jun; 44(6):632-9. PubMed ID: 19806896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 1st Communication: balance of elimination, plasma and blood kinetics, metabolism in rats.
    Tufenkji AE; Campistron G; Malbosc R; Declume C; Dormard Y; Atabakhsh F; Benard P; Houin G
    Arzneimittelforschung; 1993 Mar; 43(3):323-6. PubMed ID: 8489560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats.
    Krishna R; Shah VR; Srinivas N
    Biopharm Drug Dispos; 2002 Sep; 23(6):233-7. PubMed ID: 12214323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine.
    Lu T; Yang J; Gao X; Chen P; Du F; Sun Y; Wang F; Xu F; Shang H; Huang Y; Wang Y; Wan R; Liu C; Zhang B; Li C
    Drug Metab Dispos; 2008 Aug; 36(8):1578-86. PubMed ID: 18474682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.